Supplemental material
Journal of Biomolecular Structure and Dynamics
Volume 38, 2020 - Issue 18
Research Articles
Design potential selective inhibitors for human leukocyte common antigen-related (PTP-LAR) with fragment replace approach
Jing-Wei WuTianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, China; 
http://orcid.org/0000-0002-0285-3619View further author information
http://orcid.org/0000-0002-0285-3619View further author information, , , , , , , & show allReprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
Design potential selective inhibitors for human leukocyte common antigen-related (PTP-LAR) with fragment replace approach
Source:
Taylor & Francis
Design potential selective inhibitors for human leukocyte common antigen-related (PTP-LAR) with fragment replace approach
Source:
Taylor & Francis
Design potential selective inhibitors for human leukocyte common antigen-related (PTP-LAR) with fragment replace approach
Source:
Taylor & Francis
Linking provided by
